Lipoprotein Insulin Resistance Index: A Lipoprotein Particle–Derived Measure of Insulin Resistance

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release

(2013) W. Timothy Garvey et al.   DIABETES CARE

AACE Comprehensive Diabetes Management Algorithm 2013 Endocrine Practice

(2013) Héctor Tamez-Pérez et al.   Endocrine Practice

New Tools for Weight-Loss Therapy Enable a More Robust Medical Model for Obesity Treatment: Rationale for a Complications-Centric Approach

(2013) W. Garvey   Endocrine Practice

American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement - Executive Summary

(2013) Alan Garber et al.   Endocrine Practice

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

(2013) et al.   EUROPEAN HEART JOURNAL

Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program

(2013) R. Goldberg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of colesevelam and niacin on low-density lipoprotein cholesterol and glycemic control in subjects with dyslipidemia and impaired fasting glucose

(2013) Michael H. Davidson et al.   Journal of Clinical Lipidology

A complications-based clinical staging of obesity to guide treatment modality and intensity

(2013) Sunil Daniel et al.   Current Opinion in Endocrinology Diabetes and Obesity

Limitations in the Use of Indices Using Glucose and Insulin Levels to Predict Insulin Sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans

(2012) V. Pisprasert et al.   DIABETES CARE

Opportunities for Using Lipoprotein Subclass Profile by Nuclear Magnetic Resonance Spectroscopy in Assessing Insulin Resistance and Diabetes Prediction

(2012) Alexis C. Frazier-Wood et al.   Metabolic Syndrome and Related Disorders

Effects of Niacin on Glucose Control in Patients With Dyslipidemia

(2009) Ronald B. Goldberg et al.   MAYO CLINIC PROCEEDINGS

A Step Backward--or Is it Forward?

(2008) S. Genuth et al.   DIABETES CARE

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage

(2007) Ranganath Muniyappa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM